← Back to Search

Hearing Aid for Hearing Loss

N/A
Waitlist Available
Research Sponsored by Sonova AG
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
N3-N4 hearing loss
18-85 years of age
Must not have
Self-reported active ear-related pathology (otorrhea, dizziness, sudden hearing loss or worsening of hearing, otalgia)
Visible deformity of the ear
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day
Awards & highlights
No Placebo-Only Group

Summary

This trial will collect information on how well a new noise reduction feature works in helping people hear and understand speech better in noisy environments when using a vented earmold.

Who is the study for?
This trial is for English-speaking adults aged 18-85 with moderate to severe hearing loss, who are experienced in using hearing aids. They should be able to perform complex tasks and commit to the data collection period. People with ear-related issues, visible ear deformities, one-sided hearing loss, cognitive impairments or severe tinnitus cannot participate.
What is being tested?
The study is testing how well a Phonak Audeo Infinio Hearing Aid helps understand speech in noisy environments when it has different venting configurations combined with a new noise reduction feature.
What are the potential side effects?
While not explicitly stated, typical side effects of using hearing aids may include discomfort or irritation in the ear canal, feedback noises, and difficulties adapting to amplified sounds.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have severe to profound hearing loss.
Select...
I am between 18 and 85 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am experiencing ear problems like pain, hearing loss, or dizziness.
Select...
I have a visible ear deformity.
Select...
I have long-term, severe ringing in my ears.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
AZ Bio Sentences

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: ExperimentalExperimental Treatment1 Intervention
All participants will be tested using all three types of domes: Power, Vented, Open.

Find a Location

Who is running the clinical trial?

Sonova AGLead Sponsor
82 Previous Clinical Trials
1,948 Total Patients Enrolled
74 Trials studying Hearing Loss
1,754 Patients Enrolled for Hearing Loss
~13 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top